Edwards Lifesciences (EW) Share-based Compensation Growth (5y) (2014 - 2026)
Powered by 
Analysis
Edwards Lifesciences (EW) Share-based Compensation Growth (5y) (2014 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.82 Bn | 177.22 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 123.46 Bn | 118.24 Bn | 1.96 Bn |
| 3 | Medtronic | 117.15 Bn | 108.33 Bn | 6.34 Bn |
| 4 | Stryker | 105.55 Bn | 102.07 Bn | 4.50 Bn |
| 5 | Boston Scientific | 64.84 Bn | 64.30 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 49.45 Bn | 45.19 Bn | 1.35 Bn |
| 7 | Alcon | 33.15 Bn | 31.70 Bn | 1.68 Bn |
| 8 | Dexcom | 31.78 Bn | 29.83 Bn | 830.00 Mn |
| 9 | Steris | 20.74 Bn | 20.26 Bn | 684.20 Mn |
| 10 | Zimmer Biomet Holdings | 18.01 Bn | 17.60 Bn | 1.54 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 6.85% |
| Mar 31, 2026 | 9.99% |
| Dec 31, 2025 | 13.40% |
| Sep 30, 2025 | 12.37% |
| Jun 30, 2025 | 8.62% |
| Mar 31, 2025 | 10.96% |
| Dec 31, 2024 | 11.49% |
| Sep 30, 2024 | 16.28% |
| Jun 30, 2024 | 14.51% |
| Mar 31, 2024 | 16.48% |
| Dec 31, 2023 | 13.77% |
| Sep 30, 2023 | 13.38% |
| Jun 30, 2023 | 62.51% |
| Mar 31, 2023 | 2.55% |
| Dec 31, 2022 | 12.77% |
| Sep 30, 2022 | 13.91% |
| Jun 30, 2022 | 18.80% |
| Mar 31, 2022 | 16.34% |
| Dec 31, 2021 | 11.73% |
| Sep 30, 2021 | 13.06% |